🚨NEW @ascocancer.bsky.social #EduBook chapter:
@hoperugo.bsky.social, @stolaney1.bsky.social &
I unpack the most debated trial design issues in m+ #BreastCancer —suboptimal control arms, crossover challenges, post-progression tx, non-inferiority margins, patient selection. ➡️ shorturl.at/nZWdI #bcsm
2
0
0
0